Robotically-assisted surgical devices company Virtual Incision has raised $18 million in Series B funding. The round was co-led by new investor Sinopharm Capital, the private equity fund initiated by Chinese healthcare company Sinopharm Group, and existing investor Bluestem Capital, with participation from PrairieGold Venture Partners.

[Image courtesy: Virtual Incision]